GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » Ending Cash Position

Ind-Swift Laboratories (NSE:INDSWFTLAB) Ending Cash Position : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories Ending Cash Position?

Ind-Swift Laboratories's Ending Cash Position for the quarter that ended in Dec. 2023 was ₹0 Mil.

Ind-Swift Laboratories's annual Ending Cash Position increased from Mar. 2021 (₹116 Mil) to Mar. 2022 (₹258 Mil) but then declined from Mar. 2022 (₹258 Mil) to Mar. 2023 (₹171 Mil).

Ind-Swift Laboratories Ending Cash Position Historical Data

The historical data trend for Ind-Swift Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories Ending Cash Position Chart

Ind-Swift Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 322.07 128.49 116.11 257.70 170.72

Ind-Swift Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ind-Swift Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Ind-Swift Laboratories's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=214.776+-44.061
=171

Ind-Swift Laboratories's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0

Ind-Swift Laboratories Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » Ending Cash Position
Comparable Companies
BOM:532649 BOM:506414 BOM:524075 BOM:541400 NSE:SAKAR BOM:532039 BOM:524500 BOM:540937 BOM:539730 BOM:526953 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
532305:India
Address
SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh, PB, IND, 160 101
Website
https://www.indswiftlabs.com
Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Headlines

No Headlines